Litt's app available free to subscribers - download for IOS and Android from the App Store or Google Play.
- TRADE NAMES: Aclasta (Novartis); Reclast (Novartis); Zometa (Novartis)
- INDICATIONS: Hypercalcemia of malignancy, Paget's disease, osteoporosis
- SYNONYM: zoledronic acid
- CLASS: Bisphosphonate
- HALF-LIFE: 7 days
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Aminoglycosides, Bisphosphonates, Loop diuretics, Nephrotoxics
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Click on the DRUG REVIEW ARTICLE tab (above) to see a review of zoledronate in the Taylor & Francis journal Expert Opinion on Drug Safety.
(Note that non-subscribers to the journal will only be able to see an abstract of the article.)
Page last updated 10/21/2023
